To date, clinical trials involving MenSCs have primarily evaluated their therapeutic effects in diseases such as multiple sclerosis, H7N9 influenza virus infection, severe COVID-19, Ashermans syndrome, and ovarian insufficiency (Zhong et al., 2009
As we age, our bodies naturally produce less of the foundational compounds that keep our skin looking firm and resilient
BPC-157 loses its advantage when the injury is too distributed for a single injection site to cover
All gastrointestinal disorder events were mild to moderate in severity
10.1016/j.vph.2018.02.010 [DOI] [PubMed] [Google Scholar] Vukojevic J., Vrdoljak B., Malekinusic D., Siroglavic M., Milavic M., Kolenc D., et al